Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:49:02 EDT Mon 29 Apr 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
T:APS
- APTOSE BIOSCIENCES INC. -
http://aptose.com/
05:49:02 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
APS
- T
↑ATS
0.3
1.65
·
1.75
1.1
1.70
+0.08
4.9
50.4
69
267
1.68
1.77
1.60
11.40 1.59
Apr 26
Mar 26
15 min
RT 2¢
TSX - T
0.3
1.65
·
1.75
1.1
1.70
+0.08
4.9
34.4
48
164
1.68
1.77
1.60
11.40 1.59
Apr 26
15 min
NEO ATS - U
1.67
+0.05
3.1
1.2
1
12
1.63
1.77
1.63
Apr 26
15 min
Alpha - A
1.68
+0.06
3.7
1.2
2
5
1.68
1.70
1.68
Apr 26
15 min
Pure - P
1.67
+0.05
3.1
0.2
0
2
1.69
1.69
1.67
Apr 26
15 min
Chi-X - X
1.69
+0.07
4.3
1.5
2
12
1.67
1.75
1.63
Apr 26
15 min
CX2 - H
1.70
+0.08
4.9
6.2
10
16
1.60
1.75
1.60
Apr 26
15 min
CXD - D
1.72
+0.10
6.2
1.2
1
16
1.68
1.76
1.68
Apr 26
15 min
TriAct - M
1.62
4.4
6
39
Sep 11-20
15 min
CS2 - S
1.70
+0.08
4.9
0.1
0
1
1.70
1.70
1.70
Apr 26
15 min
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information
Hide ATS
·
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
Company
·
Participants
·
1yr Bulletins
·
Sedar
·
Historical
·
Options
·
Shorts
·
Portfolio
Recent Trades - Last 10 of 267
More trades...
Time ET
Ex
Price
Change
Volume
Buyer
Seller
Markers
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Price
Type
Headline
2024-03-26 18:23
C:APS
2.13
SEDAR Annual Report
803
SEDAR Annual Report
2024-03-26 18:16
C:APS
2.13
SEDAR MD & A
815
SEDAR MD & A
2024-03-26 18:03
C:APS
2.13
SEDAR Audited Annual Financial Statements
804
SEDAR Audited Annual Financial Statements
2024-03-26 16:26
C:APS
2.13
News Release
200
Aptose Biosciences spends $33.27M on R&D in 2023
2024-03-18 16:43
C:APS
2.00
News Release
200
Aptose to release 2023 results, host call March 26
2024-01-31 16:10
C:APS
2.63
News Release
200
Aptose closes financings for $13.7-million (U.S.)
2024-01-26 10:25
C:APS
2.64
News Release
200
Aptose prices offering at $1.71 (U.S.) per share
2023-12-11 01:17
C:APS
3.80
News Release
200
Aptose releases tuspetinib data from phase 1/2 study
2023-11-30 17:13
C:APS
3.32
News Release
200
Aptose Biosciences adds executive duties to Payne
2023-11-09 18:39
C:APS
4.27
SEDAR Interim MD & A
813
SEDAR Interim MD & A
2023-11-09 18:30
C:APS
4.27
SEDAR Interim Financial Statements
812
SEDAR Interim Financial Statements
2023-11-09 16:09
C:APS
4.27
News Release
200
Aptose spends $8.25-million on R&D in Q3
2023-10-30 11:47
C:APS
3.80
News Release
200
Aptose talks Aptivate study results, ESH conference
2023-10-26 11:51
C:APS
3.49
News Release
200
Aptose to release Q3 2023 results Nov. 9
2023-10-23 12:50
C:APS
3.20
News Release
200
Aptose to provide clinical update at ESH conference
2023-09-06 14:09
C:APS
5.59
News Release
200
Aptose Biosciences closes $3M investment by Hanmi
2023-08-10 16:49
C:APS
5.15
SEDAR Interim Financial Statements
812
SEDAR Interim Financial Statements
2023-08-10 16:33
C:APS
5.15
News Release
200
Aptose cash at $23.3-million at June 30
2023-07-27 16:17
C:APS
5.20
News Release
200
Aptose to release Q2 results, host call Aug. 10
2023-06-26 17:19
C:APS
7.00
News Release
200
Aptose regains Nasdaq compliance after share rollback